A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis

Exclusion Criteria

• •1. Subjects who have taken or are currently taking glycopyrronium cloth, 2.4%.
• •2. Prior surgical procedure for hyperhidrosis.
• •3. Iontophoresis for the palms within 4 weeks of Baseline.
• •4. Treatment with botulinum toxin (e.g., Botox®) for palmar hyperhidrosis within 1 year of Baseline.
• •5. Open wounds or inflammatory lesions on the hands or, any condition that may alter the barrier function of the skin on the hands.
• •6. Secondary palmar hyperhidrosis or presence of a condition that may cause secondary hyperhidrosis (e.g., lymphoma, malaria, severe anxiety not controlled by medication, carcinoid syndrome, substance abuse, hyperthyroidism).
• •7. Known history of Sjögren's syndrome or Sicca syndrome.
• •8. History of glaucoma, inflammatory bowel disease, toxic megacolon, active febrile illness, paralytic ileus, unstable cardiovascular status in acute hemorrhage, severe ulcerative colitis, toxic megacolon complicating ulcerative colitis or myasthenia gravis.
• •9. Men with a history of urinary retention requiring catheterization due to prostatic hypertrophy or severe obstructive symptoms of prostatic hypertrophy.